Sodium Bicarbonate Tablets 

Product Composition & Strength

We supply this product as a Precision-Blended Film-Coated or Uncoated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to prevent the highly reactive API from absorbing ambient humidity.

Active Ingredient	Strength	Primary Clinical Function
Sodium Bicarbonate USP/Ph.Eur.	1000 mg	Clinical Nephrology Standard: High-dose systemic alkalinization for the management of metabolic acidosis.
Excipients	Microcrystalline Cellulose / Croscarmellose Sodium / Stearic Acid / Magnesium Stearate	Diluent / Superdisintegrant / Lubricant (Engineered for immediate dissolution without premature effervescence)

*Pack Sizes: Bottles of 100 or 10x10 Alu-Alu Blisters (Optimized specifically for strict, high-volume chronic nephrology regimens where patients consume multiple grams daily).

Sodium Bicarbonate Tablets 

Sodium Bicarbonate Tablets USP (1000 mg)

Healthy Inc is a specialized global supplier and exporter of advanced nephrological, metabolic, and critical-care therapeutics. We provide ultra-high-purity, pharmacopeially validated Sodium Bicarbonate Tablets USP (1000 mg), manufactured in WHO–GMP certified, highly climate-controlled oral solid dosage facilities. This "High-Dose Systemic Alkalinizing Agent" is a massive-volume, life-sustaining export to nephrology centers, dialysis clinics, urology networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally mandated intervention for metabolic acidosis in Chronic Kidney Disease (CKD).

Product Overview

This formulation contains a massive, clinical dose of Sodium Bicarbonate (1000 mg), a highly potent systemic and urinary alkalinizer that acts as the body's primary buffering agent to maintain strict physiological pH. The "Metabolic Acidosis & Nephrology" Specialist:

• Mechanism 1 (The Systemic Buffer - CKD Shield): In Chronic Kidney Disease (CKD), the failing kidneys lose their ability to excrete daily dietary acid, leading to a dangerous buildup of hydrogen ions in the blood (Metabolic Acidosis). The 1000 mg Sodium Bicarbonate tablet floods the bloodstream with bicarbonate ions (HCO3-). These ions aggressively bind to the toxic hydrogen ions, converting them into water and carbon dioxide, instantly restoring a safe blood pH and preventing the acidic blood from dissolving the patient's bones.
• Delaying Dialysis: Global nephrology guidelines mandate aggressive 1000 mg bicarbonate therapy for CKD patients because maintaining normal serum bicarbonate levels physically slows the decline of kidney function, delaying the traumatic and expensive transition to end-stage renal dialysis.
• Mechanism 2 (Urinary Alkalinization): By excreting excess bicarbonate into the urine, this medication drastically raises urinary pH. This serves as a highly effective prophylactic treatment against uric acid kidney stones.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Nephrology Distributors, and Hospital Procurement Boards.

HS Code	3004.90.99 (Medicaments containing other active substances - Alkalinizers)
CAS Number	144-55-8
Dosage Form	Tablet (Immediate Release)
Packaging	Alu-Alu Blisters or Moisture-Barrier HDPE Bottles (STRICTLY MANDATORY). Strict barrier packaging guarantees multi-year shelf life across Zone IVb tropical climates.
Storage	Store strictly below 30°C in a dry place. Keep containers tightly closed. Protect from moisture.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Ultra-Low Humidity Compression: Manufacturing a 1000 mg dose of pure Sodium Bicarbonate requires strictly controlled, ultra-low humidity environmental suites and advanced dry-granulation techniques to guarantee absolute tablet integrity, structural hardness, and exact USP assay compliance without premature CO2 off-gassing.

Therapeutic Indications (Human Use)

• Chronic Kidney Disease (CKD): Management of metabolic acidosis in patients with renal failure to slow disease progression.
• Urinary Alkalinization: Prophylaxis against uric acid and cystine kidney stones.

Dosage & Administration

• Standard Adult Dosing (Metabolic Acidosis): Dosing is highly individualized. A typical starting dose is 1000 mg to 2000 mg (1 to 2 tablets) taken 2 to 3 times a day.
• Administration (THE WATER RULE): Tablets MUST be taken with a full glass of water to prevent severe gastric distention.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Sodium Overload (Edema & Heart Failure Risk): Each 1000 mg tablet contains approximately 274 mg of elemental sodium (11.9 mEq). This massive sodium load can trigger severe fluid retention in CKD patients.
• Hypokalemia Risk: Rapid correction of acidosis forces potassium into the cells, potentially causing severe, life-threatening hypokalemia.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders and Retail Pharmacy Networks. We offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Nephrological Formulations. Whether you need a Hospital Tender Supplier for dialysis networks in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery of WHO-GMP certified products at competitive rates. https://healthyinc.co.in/product/sodium-bicorbonate-tablets/